Obesity and type 2 diabetes are associated with disturbances in insulin-regulated glucose and lipid fluxes and severe comorbidities including cardiovascular disease and steatohepatitis. Whole body metabolism is regulated by lipid-storing white adipocytes as well as "brown" and "brite/beige" adipocytes that express thermogenic uncoupling protein 1 (UCP1) and secrete factors favorable to metabolic health. Implantation of brown fat into obese mice improves glucose tolerance, but translation to humans has been stymied by low abundance of primary human beige adipocytes. Here we apply methods to greatly expand human adipocyte progenitors from small samples of human subcutaneous adipose tissue and then disrupt the thermogenic suppressor gene NRIP1 by CRISPR. Ribonucleoprotein consisting of Cas9 and sgRNA delivered ex vivo are fully degraded by the human cells following high efficiency NRIP1 depletion without detectable off-target editing. Implantation of such CRISPR-enhanced human or mouse brown-like adipocytes into high fat diet fed mice decreases adiposity and liver triglycerides while enhancing glucose tolerance compared to implantation with unmodified adipocytes. These findings advance a therapeutic strategy to improve metabolic homeostasis through CRISPR-based genetic enhancement of human adipocytes without exposing the recipient to immunogenic Cas9 or delivery vectors.

Department of Molecular Cell and Cancer Biology University of Massachusetts Medical School Worcester MA 01605 USA

Division of Endocrinology Metabolism and Diabetes Department of Medicine University of Massachusetts Medical School Worcester MA 01605 USA

Li Weibo Institute for Rare Diseases Research University of Massachusetts Medical School Worcester MA 01605 USA

Program in Molecular Medicine University of Massachusetts Medical School Worcester MA 01605 USA

RNA Therapeutics Institute University of Massachusetts Medical School Worcester MA 01605 USA

University of Crete School of Medicine Crete 71003 Greece

000      

00000naa a2200000 a 4500

001      

bmc22011891

003      

CZ-PrNML

005      

20220506131240.0

007      

ta

008      

220425s2021 xxk f 000 0|eng||

009      

AR

024    7_

$a 10.1038/s41467-021-27190-y $2 doi

035    __

$a (PubMed)34836963

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxk

100    1_

$a Tsagkaraki, Emmanouela $u Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA $u University of Crete School of Medicine, Crete, 71003, Greece $1 https://orcid.org/0000000177548945

245    10

$a CRISPR-enhanced human adipocyte browning as cell therapy for metabolic disease / $c E. Tsagkaraki, SM. Nicoloro, T. DeSouza, J. Solivan-Rivera, A. Desai, LM. Lifshitz, Y. Shen, M. Kelly, A. Guilherme, F. Henriques, N. Amrani, R. Ibraheim, TC. Rodriguez, K. Luk, S. Maitland, RH. Friedline, L. Tauer, X. Hu, JK. Kim, SA. Wolfe, EJ. Sontheimer, S. Corvera, MP. Czech

520    9_

$a Obesity and type 2 diabetes are associated with disturbances in insulin-regulated glucose and lipid fluxes and severe comorbidities including cardiovascular disease and steatohepatitis. Whole body metabolism is regulated by lipid-storing white adipocytes as well as "brown" and "brite/beige" adipocytes that express thermogenic uncoupling protein 1 (UCP1) and secrete factors favorable to metabolic health. Implantation of brown fat into obese mice improves glucose tolerance, but translation to humans has been stymied by low abundance of primary human beige adipocytes. Here we apply methods to greatly expand human adipocyte progenitors from small samples of human subcutaneous adipose tissue and then disrupt the thermogenic suppressor gene NRIP1 by CRISPR. Ribonucleoprotein consisting of Cas9 and sgRNA delivered ex vivo are fully degraded by the human cells following high efficiency NRIP1 depletion without detectable off-target editing. Implantation of such CRISPR-enhanced human or mouse brown-like adipocytes into high fat diet fed mice decreases adiposity and liver triglycerides while enhancing glucose tolerance compared to implantation with unmodified adipocytes. These findings advance a therapeutic strategy to improve metabolic homeostasis through CRISPR-based genetic enhancement of human adipocytes without exposing the recipient to immunogenic Cas9 or delivery vectors.

650    _2

$a hnědé tukové buňky $x metabolismus $x transplantace $7 D052437

650    _2

$a bílé tukové buňky $x metabolismus $7 D052438

650    _2

$a dospělé kmenové buňky $x fyziologie $7 D053687

650    _2

$a zvířata $7 D000818

650    _2

$a CRISPR-Cas systémy $x genetika $7 D064113

650    _2

$a buněčné kultury $x metody $7 D018929

650    _2

$a buněčná diferenciace $7 D002454

650    _2

$a dieta s vysokým obsahem tuků $x škodlivé účinky $7 D059305

650    _2

$a modely nemocí na zvířatech $7 D004195

650    _2

$a ztučnělá játra $x etiologie $x metabolismus $x prevence a kontrola $7 D005234

650    _2

$a editace genu $x metody $7 D000072669

650    _2

$a porucha glukózové tolerance $x etiologie $x metabolismus $x terapie $7 D018149

650    _2

$a lidé $7 D006801

650    _2

$a metabolismus lipidů $x genetika $7 D050356

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a myši $7 D051379

650    _2

$a nuclear receptor interacting protein 1 $x genetika $x metabolismus $7 D000078723

650    _2

$a obezita $x komplikace $x metabolismus $x terapie $7 D009765

650    _2

$a guide RNA, Kinetoplastida $x genetika $7 D017394

650    _2

$a podkožní tuk $x cytologie $7 D050151

650    _2

$a termogeneze $x genetika $7 D022722

655    _2

$a časopisecké články $7 D016428

655    _2

$a Research Support, N.I.H., Extramural $7 D052061

655    _2

$a práce podpořená grantem $7 D013485

655    _2

$a Research Support, U.S. Gov't, Non-P.H.S. $7 D013486

700    1_

$a Nicoloro, Sarah M $u Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA $1 https://orcid.org/0000000286384556

700    1_

$a DeSouza, Tiffany $u Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA

700    1_

$a Solivan-Rivera, Javier $u Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA

700    1_

$a Desai, Anand $u Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA

700    1_

$a Lifshitz, Lawrence M $u Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA

700    1_

$a Shen, Yuefei $u Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA

700    1_

$a Kelly, Mark $u Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA $1 https://orcid.org/000000019018594X

700    1_

$a Guilherme, Adilson $u Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA $1 https://orcid.org/0000000305355911

700    1_

$a Henriques, Felipe $u Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA $1 https://orcid.org/0000000292457141

700    1_

$a Amrani, Nadia $u University of Crete School of Medicine, Crete, 71003, Greece

700    1_

$a Ibraheim, Raed $u RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA $1 https://orcid.org/0000000209617299

700    1_

$a Rodriguez, Tomas C $u RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA $1 https://orcid.org/0000000287245427

700    1_

$a Luk, Kevin $u Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA, 01605, USA

700    1_

$a Maitland, Stacy $u Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA, 01605, USA

700    1_

$a Friedline, Randall H $u Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA $1 https://orcid.org/000000030894448X

700    1_

$a Tauer, Lauren $u Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA $1 https://orcid.org/0000000223151050

700    1_

$a Hu, Xiaodi $u Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA

700    1_

$a Kim, Jason K $u Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA $u Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA $1 https://orcid.org/000000027185042X

700    1_

$a Wolfe, Scot A $u Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA, 01605, USA $u Li Weibo Institute for Rare Diseases Research, University of Massachusetts Medical School, Worcester, MA, 01605, USA $1 https://orcid.org/000000027042201X

700    1_

$a Sontheimer, Erik J $u Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA $u RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, 01605, USA $u Li Weibo Institute for Rare Diseases Research, University of Massachusetts Medical School, Worcester, MA, 01605, USA $1 https://orcid.org/0000000208810310

700    1_

$a Corvera, Silvia $u Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA. Silvia.Corvera@umassmed.edu $1 https://orcid.org/0000000200094129

700    1_

$a Czech, Michael P $u Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, 01605, USA. Michael.Czech@umassmed.edu $1 https://orcid.org/0000000340757350

773    0_

$w MED00184850 $t Nature communications $x 2041-1723 $g Roč. 12, č. 1 (2021), s. 6931

856    41

$u https://pubmed.ncbi.nlm.nih.gov/34836963 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y p $z 0

990    __

$a 20220425 $b ABA008

991    __

$a 20220506131232 $b ABA008

999    __

$a ok $b bmc $g 1789476 $s 1163092

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2021 $b 12 $c 1 $d 6931 $e 20211126 $i 2041-1723 $m Nature communications $n Nat Commun $x MED00184850

GRA    __

$a UH3 TR002668 $p NCATS NIH HHS $2 United States

GRA    __

$a F31 HL147482 $p NHLBI NIH HHS $2 United States

GRA    __

$a R37 DK030898 $p NIDDK NIH HHS $2 United States

GRA    __

$a R01 DK030898 $p NIDDK NIH HHS $2 United States

GRA    __

$a R01 GM115911 $p NIGMS NIH HHS $2 United States

GRA    __

$a UG3 TR002668 $p NCATS NIH HHS $2 United States

GRA    __

$a U2C DK093000 $p NIDDK NIH HHS $2 United States

LZP    __

$a Pubmed-20220425